BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8586113)

  • 1. Bioequivalence of inhaled drugs.
    Derom E; Pauwels R
    Eur Respir J; 1995 Oct; 8(10):1634-6. PubMed ID: 8586113
    [No Abstract]   [Full Text] [Related]  

  • 2. [Adaptations of the European Respiratory Society guidelines by the Aerosol Therapy Group of the French Lung Society on the use of aerosol therapy through nebulization].
    Boe J; Dennis JH; O'Driscoll BR; Bauer TT; Carone M; Dautzenberg B; Diot P; Heslop K; Lannefors L;
    Rev Mal Respir; 2004 Nov; 21(5 Pt 1):1033-8. PubMed ID: 15622355
    [No Abstract]   [Full Text] [Related]  

  • 3. [Adaptations of the European Respiratory Society guidelines by the Aerosol Therapy Group of the French Lung Society on the use of aerosol therapy through nebulization].
    Becquemin MH; Chaumuzeau JP
    Rev Mal Respir; 2004 Nov; 21(5 Pt 1):889-90. PubMed ID: 15622332
    [No Abstract]   [Full Text] [Related]  

  • 4. [Modern methods of inhalation therapy of respiratory diseases].
    Zaitsev AA; Kharitonov MA
    Voen Med Zh; 2015 Jun; 336(6):20-4. PubMed ID: 26442311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhalation Devices.
    Moroni-Zentgraf P; Usmani OS; Halpin DMG
    Can Respir J; 2018; 2018():5642074. PubMed ID: 30319720
    [No Abstract]   [Full Text] [Related]  

  • 6. [Guideline for the use of inhaled drugs. The Working Group of SEPAR: the Nursing Area of the Sociedad Española de Neumología y Cirugía Torácica].
    Giner J; Basualdo LV; Casan P; Hernández C; Macián V; Martínez I; Mengíbar A
    Arch Bronconeumol; 2000 Jan; 36(1):34-43. PubMed ID: 10726183
    [No Abstract]   [Full Text] [Related]  

  • 7. A respiratory product for children--development and submission experiences.
    Leiner S
    Int J Pharm; 2014 Aug; 469(2):263-4. PubMed ID: 24560645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioequivalence assessment of inhalation products: Interchangeability, study design and statistical methods.
    Arieta AG
    Pulm Pharmacol Ther; 2010 Jun; 23(3):156-8. PubMed ID: 20064625
    [No Abstract]   [Full Text] [Related]  

  • 9. Drugs for asthma and COPD.
    Treat Guidel Med Lett; 2013 Aug; 11(132):75-86; quiz following 86. PubMed ID: 23896773
    [No Abstract]   [Full Text] [Related]  

  • 10. Targeting drugs to the lungs. Proceedings of a workshop. Bagshot, Surrey, United Kingdom, June 1997.
    Respir Med; 1997 Nov; 91 Suppl A():1-41. PubMed ID: 9490455
    [No Abstract]   [Full Text] [Related]  

  • 11. Pulmonary effect of inhaled furosemide in ventilated infants with severe bronchopulmonary dysplasia.
    Prabhu VG
    Pediatrics; 1997 Sep; 100(3 Pt 1):420-1. PubMed ID: 9304111
    [No Abstract]   [Full Text] [Related]  

  • 12. Guidance on handheld inhalers in asthma and COPD guidelines.
    Dekhuijzen PN; Bjermer L; Lavorini F; Ninane V; Molimard M; Haughney J
    Respir Med; 2014 May; 108(5):694-700. PubMed ID: 24636812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancing adherence to inhaled therapies in cystic fibrosis.
    Lomas P
    Ther Adv Respir Dis; 2014 Apr; 8(2):39-47. PubMed ID: 24594976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Product lifecycle approach to cascade impaction measurements.
    Tougas TP; Christopher D; Mitchell J; Lyapustina S; Van Oort M; Bauer R; Glaab V
    AAPS PharmSciTech; 2011 Mar; 12(1):312-22. PubMed ID: 21286882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic equivalence of inhaled salbutamol.
    Fowler SJ; Lipworth BJ
    Thorax; 2000 Apr; 55(4):347-8. PubMed ID: 10766648
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhaled medication and inhalation devices for lung disease in patients with cystic fibrosis: A European consensus.
    Heijerman H; Westerman E; Conway S; Touw D; Döring G;
    J Cyst Fibros; 2009 Sep; 8(5):295-315. PubMed ID: 19559658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nebulized therapy. SEPAR year.
    Olveira C; Muñoz A; Domenech A
    Arch Bronconeumol; 2014 Dec; 50(12):535-45. PubMed ID: 24997131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Considerations in establishing bioequivalence of inhaled compounds.
    Mayers I; Bhutani M
    Expert Opin Drug Deliv; 2018 Feb; 15(2):153-162. PubMed ID: 28918665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Requirements, Strengths and Weaknesses of Inhaler Devices for COPD Patients from the Expert Prescribers' Point of View: Results of the EPOCA Delphi Consensus.
    García-Río F; Soler-Cataluña JJ; Alcazar B; Viejo JL; Miravitlles M
    COPD; 2017 Dec; 14(6):573-580. PubMed ID: 28891722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Standards of aerosol therapy.
    Klein AV; Roufail P
    CMAJ; 1993 Nov; 149(9):1226. PubMed ID: 8221469
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.